|
|
Aerobic Function in Aging Skeletal Muscle: From Molecular to Systemic
Mechanisms
Sponsored by the APS Muscle Biology Group
Tues. April 4—10:30 AM-12:30 PM
|
| Chaired: |
Harry B. Rossiter, Univ. of Leeds
Russell T. Hepple, Univ. of Calgary |
The ability to sustain muscular exercise depends on the effective
integration of oxygen transport to, and oxygen utilization by, skeletal
muscle mitochondria. With advancing age the systems that determine this
ability (such as the maximal rates of cardiac output, limb blood flow,
mitochondrial oxidative phosphorylation) become progressively limited.
These declines arise in molecular, mitochondrial and systemic functions
that, in the extreme, limit the aged persons’ ability to maintain an
adequate quality of life. With respect to skeletal muscle and aging, much
attention is paid to the effects of sarcopenia and consequential effects
on muscle power generation (158 citations on Pubmed1), however,
we contend, that relatively little attention is paid to the mechanisms of
aerobic function decline (30 citations on Pubmed2) during
senescence; naturally both of these are required for effective power
generation that can be sustained for functionally meaningful durations.
The proposed symposium will focus on the integration of age-related
declines from multiple levels of investigation: the limitations to
systemic function will be addressed from intramuscular molecular function
to whole-muscle O2 delivery, encompassing both cellular and
integrative approaches. The first speaker, Dr. John Kowalchuk, will
describe the “status of the problem”, illustrating the systemic
limitations to exercise tolerance in senescent humans, with particular
stress on the mediation of the non-steady-state responses of
cardiovascular and aerobic skeletal muscle function. Following this, the
talks will focus on progressive steps down the oxygen cascade from O2
delivery, via the mitochondrion, to cell signaling. Dr. David Poole will
present recent findings on how aging alters skeletal muscle vascular
geometry and vascular control such that blood flow and oxygen delivery are
impaired in aging. Dr. Kevin Short will then present how the decline in
muscle oxidative phosphorylation with aging is related to reduced
mitochondrial synthesis and mitochondrial dysfunction (resulting from
mitochondrial DNA damage, oxidative damage and uncoupling). Finally, Dr.
Frank Booth, will highlight the age-related impairment in various cellular
signaling pathways in skeletal muscle and their effects on skeletal muscle
regeneration. We aim, therefore, to highlight the current state of
knowledge regarding impairment of exercise tolerance in healthy, but aged,
humans, and to discuss how these relate to oxygen delivery, mitochondrial,
and molecular limitations to aerobic function in aged skeletal muscle.
[1 Search criteria: skeletal muscle AND aging AND sarcopenia
(April 2005)]
[2 Search criteria: skeletal muscle AND aging AND oxidative
phosphorylation (April 2005)]
|
10:30 AM |
Ageing and limitations to muscle O2 consumption – a whole body
approach.
John M. Kowalchuk, Univ. of Western Ontario
|
|
11:00 AM |
Microcirculatory hemodynamics and oxygenation in aged muscle.
David C. Poole, Kansas State Univ.
|
|
11:30 AM |
Decline in muscle mitochondrial function with aging.
Kevin R. Short, Mayo Clinic
|
|
12:00 Noon |
Impaired growth in old skeletal muscle.
Frank W. Booth, University of Missouri-Columbia
|
|
|